Pharsight

1. Annovera patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10765628	THERAPEUTICSMD INC	Method of providing birth control	Feb, 2039 (15 years from now)
US10632066	THERAPEUTICSMD INC	Method of providing birth control	Feb, 2039 (15 years from now)
US10780047	THERAPEUTICSMD INC	Method of providing birth control	Feb, 2039 (15 years from now)
US10925882	THERAPEUTICSMD INC	System for providing birth control	Jun, 2039 (15 years from now)
US11529308	THERAPEUTICSMD INC	System for providing birth control	Jun, 2039 (15 years from now)
US10940157	THERAPEUTICSMD INC	System for providing birth control	Jun, 2039 (15 years from now)
US10918649	THERAPEUTICSMD INC	System for providing birth control	Jun, 2039 (15 years from now)

Drug Exclusivity	Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE)	Aug 10, 2023

Drugs and Companies using ETHINYL ESTRADIOL; SEGESTERONE ACETATE ingredient

NCE-1 date: 2022-08-10

Market Authorisation Date: 10 August, 2018

Treatment: Method of preventing pregnancy by inserting a vaginal system containing 103 mg of segesterone acetate and 17.4 mg ethinyl estradiol into a vagina for up to thirteen 21/7-day (in/out) cycles; Method of...

Dosage: RING;VAGINAL

Strength	Dosage	Availability
0.013MG/24HR;0.15MG/24HR	RING;VAGINAL	Prescription

ANNOVERA family patents

2. Bijuva patents expiration

Application	Filing Date	Opposition Party	Legal Status

EP19163006A	2022-09-22	Dr. Schön, Neymeyr & Partner Patentanwälte mbB	Granted and Under Opposition
EP19163006A	2022-09-21	Rieck, Markus	Granted and Under Opposition
EP12850845A	2022-03-09	Dr. Schön, Neymeyr & Partner Patentanwälte mbB	Granted and Under Opposition
EP12850845A	2022-03-09	Rieck, Markus	Granted and Under Opposition
EP12850845A	2022-03-09	Generics [UK] Limited	Granted and Under Opposition
EP13807188A	2022-01-14	Rieck, Markus	Revoked
EP13807121A	2019-12-23	Rieck, Markus	Revoked

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9301920	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US10052386	THERAPEUTICSMD INC	Progesterone formulations	Nov, 2032 (9 years from now)
US10639375	THERAPEUTICSMD INC	Progesterone formulations	Nov, 2032 (9 years from now)
US8987237	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US8993548	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US11110099	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US11103516	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US10206932	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US8846649	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US8846648	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US9114146	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US9114145	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US10675288	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US11033626	THERAPEUTICSMD INC	Progesterone formulations having a desirable pk profile	Nov, 2032 (9 years from now)
US9006222	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US10806740	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US11103513	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US8933059	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US11166963	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US8633178	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)
US8993549	THERAPEUTICSMD INC	Natural combination hormone replacement formulations and therapies	Nov, 2032 (9 years from now)

Drugs and Companies using ESTRADIOL; PROGESTERONE ingredient

Market Authorisation Date: 28 October, 2018

Treatment: Treatment of menopause symptoms, including vasomotor symptoms

Dosage: CAPSULE;ORAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
1 mg/100 mg	06 Jan, 2020	1	16 May, 2022	21 Nov, 2032	Eligible

Strength	Dosage	Availability
0.5MG;100MG	CAPSULE;ORAL	Prescription
1MG;100MG	CAPSULE;ORAL	Prescription

BIJUVA family patents

3. Imvexxy patents expiration

Application	Filing Date	Opposition Party	Legal Status

EP19163006A	2022-09-22	Dr. Schön, Neymeyr & Partner Patentanwälte mbB	Granted and Under Opposition
EP19163006A	2022-09-21	Rieck, Markus	Granted and Under Opposition
EP12850845A	2022-03-09	Dr. Schön, Neymeyr & Partner Patentanwälte mbB	Granted and Under Opposition
EP12850845A	2022-03-09	Rieck, Markus	Granted and Under Opposition
EP12850845A	2022-03-09	Generics [UK] Limited	Granted and Under Opposition
EP13807188A	2022-01-14	Rieck, Markus	Revoked
EP13807121A	2019-12-23	Rieck, Markus	Revoked

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10537581	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Nov, 2032 (9 years from now)
US11246875	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Nov, 2032 (9 years from now)
US11241445	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Nov, 2032 (9 years from now)
US10835487	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Nov, 2032 (9 years from now)
US9289382	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Nov, 2032 (9 years from now)
US10806697	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Nov, 2032 (9 years from now)
US11351182	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Nov, 2032 (9 years from now)
US11304959	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Nov, 2032 (9 years from now)
US11497709	THERAPEUTICSMD INC	NA	Nov, 2032 (9 years from now)
US10568891	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Jun, 2033 (9 years from now)
US10888516	THERAPEUTICSMD INC	Soluble estradiol capsule for vaginal insertion	Jun, 2033 (9 years from now)
US11116717	THERAPEUTICSMD INC	Soluble estradiol capsule for vaginal insertion	Jun, 2033 (9 years from now)
US11065197	THERAPEUTICSMD INC	Soluble estradiol capsule for vaginal insertion	Jun, 2033 (9 years from now)
US11123283	THERAPEUTICSMD INC	Soluble estradiol capsule for vaginal insertion	Jun, 2033 (9 years from now)
US10471072	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Jun, 2033 (9 years from now)
US10668082	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Jun, 2033 (9 years from now)
US9180091	THERAPEUTICSMD INC	Soluble estradiol capsule for vaginal insertion	Dec, 2033 (10 years from now)
US10398708	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Dec, 2033 (10 years from now)
US10258630	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Dec, 2033 (10 years from now)
US11266661	THERAPEUTICSMD INC	Vaginal inserted estradiol pharmaceutical compositions and methods	Feb, 2034 (10 years from now)